• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Polyarticular juvenile idiopathic arthritis - Articles and news items

biosimilar-disease-drug

FDA approves Novartis’ biosimilar to treat multiple inflammatory diseases

Industry news / 1 September 2016 / Niamh Louise Marriott, Digital Content Producer

The FDA approval is based on analytical, nonclinical, and clinical data confirming that Erelzi is highly similar to the US-licensed reference product. Clinical studies included four comparative pharmacokinetic (PK) studies in 216 healthy volunteers and a confirmatory efficacy and safety similarity study in 531 patients with chronic plaque psoriasis…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +